Literature DB >> 31009053

Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma.

Ondřej Petrák1, Ján Rosa1, Robert Holaj1, Branislav Štrauch1, Zuzana Krátká1, Jan Kvasnička1, Judita Klímová1, Petr Waldauf2, Barbora Hamplová1, Alice Markvartová1, Květoslav Novák3, David Michalský4, Jiří Widimský1, Tomáš Zelinka1.   

Abstract

CONTEXT: Impaired diurnal blood pressure (BP) variability is related to higher cardiovascular risk.
OBJECTIVE: To assess diurnal variability of BP and its relation to target organ damage (TOD) and catecholamine phenotype in a consecutive sample of pheochromocytoma/paraganglioma (PPGL).
DESIGN: We included 179 patients with PPGL All patients underwent 24 hours of ambulatory BP monitoring to determine dipping status. Differences in plasma metanephrine or urine adrenaline were used to distinguish catecholamine biochemical phenotype. To evaluate TOD, renal functions, presence of left ventricle hypertrophy (LVH), and the subgroup (n = 111) carotid-femoral pulse wave velocity (PWV) were assessed. Structural equation modeling was used to find the relationship among nocturnal dipping, catecholamine phenotype, and TOD parameters.
RESULTS: According to the nocturnal dipping, patients were divided into the three groups: dippers (28%), nondippers (40%), and reverse dippers (32%). Reverse dippers were older (P < 0.05), with a higher proportion of noradrenergic (NA) phenotype (P < 0.05), a higher prevalence of diabetes mellitus (P < 0.05), and sustained arterial hypertension (P < 0.01) and its duration (P < 0.05), as opposed to the other groups. All parameters of TOD were more pronounced only in reverse dippers compared with nondippers and dippers. The presence of NA phenotype (=absence of adrenaline production) was associated with reverse dipping and TOD (LVH and PWV).
CONCLUSIONS: Patients with reverse dipping had more substantial TOD compared with other groups. The NA phenotype plays an important role, not only in impaired diurnal BP variability but also independently from dipping status in more pronounced TOD of heart and vessels.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31009053     DOI: 10.1210/jc.2018-02644

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study.

Authors:  Sabina Oreska; Hana Storkanova; Jaroslav Kudlicka; Vladimir Tuka; Ondrej Mikes; Zdislava Krupickova; Martin Satny; Eva Chytilova; Jan Kvasnicka; Maja Spiritovic; Barbora Hermankova; Petr Cesak; Marian Rybar; Karel Pavelka; Ladislav Senolt; Herman Mann; Jiri Vencovsky; Michal Vrablik; Michal Tomcik
Journal:  Front Med (Lausanne)       Date:  2022-05-03

2.  Influence of secretory phenotype and preoperative preparation on surgical outcome in pheochromocytoma.

Authors:  Raluca Maria Furnica; Muhammad Muddaththir Dusoruth; Alexandre Persu; Damien Gruson; Michel Mourad; Dominique Maiter
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

Review 3.  Catecholamine physiology and its implications in patients with COVID-19.

Authors:  Sriram Gubbi; Matthew A Nazari; David Taieb; Joanna Klubo-Gwiezdzinska; Karel Pacak
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10-28       Impact factor: 32.069

4.  Effect of adrenalectomy on remission of subclinical left ventricular dysfunction in patients with pheochromocytoma: a speckle-tracking echocardiography study.

Authors:  Jan Kvasnička; Ondřej Petrák; Tomáš Zelinka; Judita Klímová; Barbora Kološová; Květoslav Novák; David Michalský; Jiří Widimský; Robert Holaj
Journal:  Endocr Connect       Date:  2021-11-29       Impact factor: 3.335

Review 5.  Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.

Authors:  Gustavo F C Fagundes; Madson Q Almeida
Journal:  J Endocr Soc       Date:  2022-01-14

6.  Hypermetabolism and Substrate Utilization Rates in Pheochromocytoma and Functional Paraganglioma.

Authors:  Ondřej Petrák; Denisa Haluzíková; Judita Klímová; Matěj Zítek; Robert Holaj; David Michalský; Květoslav Novák; Radka Petráková-Doležalová; Jan Kvasnička; Thi Minh Phuong Nikrýnová Nguyen; Zuzana Krátká; Martin Matoulek; Jiří Widimský; Tomáš Zelinka
Journal:  Biomedicines       Date:  2022-08-16

7.  The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study.

Authors:  Sai-Li Duan; Lin Qi; Ming-Hao Li; Long-Fei Liu; Yong Wang; Xiao Guan
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

Review 8.  Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach.

Authors:  M Araujo-Castro; E Pascual-Corrales; L Nattero Chavez; A Martínez Lorca; T Alonso-Gordoa; J Molina-Cerrillo; J Lorca Álvaro; C Mínguez Ojeda; S Redondo López; R Barberá Durbán; R Polo López; N Moreno Mata; U Caballero Silva; H Pian; I Ruz-Caracuel; A Sanjuanbenito Dehesa; V Gómez Dos Santos; A B Serrano Romero
Journal:  J Endocrinol Invest       Date:  2021-07-25       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.